Liraglutide as an Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus

Trial Profile

Liraglutide as an Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 09 Jan 2017

At a glance

  • Drugs Liraglutide (Primary) ; Insulin
  • Indications Autoimmune disorders; Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Jan 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top